Epidemiology and Immunology of Hemophilia A Inhibitors
2 other identifiers
observational
N/A
0 countries
N/A
Brief Summary
To determine the risk factors associated with inhibitor formation in hemophilia A and to study the mechanism of tolerance in the murine hemophilia A model.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Jun 1998
Longer than P75 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 1998
CompletedFirst Submitted
Initial submission to the registry
May 25, 2000
CompletedFirst Posted
Study publicly available on registry
May 26, 2000
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2003
CompletedMay 13, 2016
August 1, 2004
May 25, 2000
May 12, 2016
Conditions
Eligibility Criteria
Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
M.V. Ragni
University of Pittsburgh
Study Design
- Study Type
- observational
- Sponsor Type
- NIH
Study Record Dates
First Submitted
May 25, 2000
First Posted
May 26, 2000
Study Start
June 1, 1998
Study Completion
August 1, 2003
Last Updated
May 13, 2016
Record last verified: 2004-08